parthenolide and Autosomal Dominant Juvenile Parkinson Disease

parthenolide has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Che, Y; Feng, X; Liu, Q; Tang, X; Zhang, S; Zhu, D1

Other Studies

1 other study(ies) available for parthenolide and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
The parthenolide derivative ACT001 synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson's disease in mice.
    Behavioural brain research, 2020, 02-03, Volume: 379

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Apoptosis; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Inflammation; Levodopa; Male; Mice; Mice, Inbred BALB C; Nerve Degeneration; Parkinson Disease; Parkinsonian Disorders; Sesquiterpenes

2020
chemdatabank.com